---
figid: PMC6468910__cancers-11-00338-g004
figlink: /pmc/articles/PMC6468910/figure/cancers-11-00338-f004/
number: F4
caption: 'ER stress and chemo-resistance: Role of inositol-requiring enzyme 1 alpha
  (IRE1), activating transcription factor 6 alpha (ATF6), and glucose-regulated protein
  78 (GRP78). Upon ERS, IRE splices and activates the X-box-binding protein 1 (XBP1)
  that controls cycline A1 expression and regulates HIF1α targets. The activation
  of IRE1 leads to the activation of c-Jun N-terminal protein kinase (JNK), followed
  by inducing AP-1 transcriptional activity. The Raf/MEK/ERK pathway is also involved
  in IRE1-mediated chemo-resistance. ATF6α possesses chemo-resistance through the
  regulation of ER chaperone BiP protein, mediated by the activation of disulfide
  isomerase A5 (PDIA5) and p38-dependent ATF6α-mTOR pathway, upon ER stress. GRP78
  exhibits its chemo-resistance properties, upon ERS, through the suppression of C/EBP
  homologous protein (CHOP), Bcl-2-interacting killer (BIK), phorbol-12-myristate-13-acetate-induced
  protein 1 (PMAIP1) or NOXA, Topo II, and induction of Bcl-2, leading to the activation
  of caspase-7 dependent apoptosis. GRP78 suppresses G1/S transition-related cyclins
  (D1, E1, and E2) and cyclin-dependent kinase (CDK4 and CDK6) protein expression.
  Additionally, the phosphorylation of GRP78 leads to the activation of Ras/MAPK and
  PI3-kinase downstream signaling, and the recruitment of p21 activated kinases 2
  (PAK-2) via NCK, thus, inhibiting the pro-apoptotic protein Bcl-2-associated death
  (Bad).'
pmcid: PMC6468910
papertitle: Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent
  Signaling.
reftext: Entaz Bahar, et al. Cancers (Basel). 2019 Mar;11(3):338.
pmc_ranked_result_index: '128581'
pathway_score: 0.95881
filename: cancers-11-00338-g004.jpg
figtitle: 'ER stress and chemo-resistance: Role of inositol-requiring enzyme 1 alpha
  (IRE1), activating transcription factor 6 alpha (ATF6), and glucose-regulated protein
  78 (GRP78)'
year: '2019'
organisms:
- Homo sapiens
ndex: f958f7cf-dedc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6468910__cancers-11-00338-g004.html
  '@type': Dataset
  description: 'ER stress and chemo-resistance: Role of inositol-requiring enzyme
    1 alpha (IRE1), activating transcription factor 6 alpha (ATF6), and glucose-regulated
    protein 78 (GRP78). Upon ERS, IRE splices and activates the X-box-binding protein
    1 (XBP1) that controls cycline A1 expression and regulates HIF1α targets. The
    activation of IRE1 leads to the activation of c-Jun N-terminal protein kinase
    (JNK), followed by inducing AP-1 transcriptional activity. The Raf/MEK/ERK pathway
    is also involved in IRE1-mediated chemo-resistance. ATF6α possesses chemo-resistance
    through the regulation of ER chaperone BiP protein, mediated by the activation
    of disulfide isomerase A5 (PDIA5) and p38-dependent ATF6α-mTOR pathway, upon ER
    stress. GRP78 exhibits its chemo-resistance properties, upon ERS, through the
    suppression of C/EBP homologous protein (CHOP), Bcl-2-interacting killer (BIK),
    phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1) or NOXA, Topo II, and
    induction of Bcl-2, leading to the activation of caspase-7 dependent apoptosis.
    GRP78 suppresses G1/S transition-related cyclins (D1, E1, and E2) and cyclin-dependent
    kinase (CDK4 and CDK6) protein expression. Additionally, the phosphorylation of
    GRP78 leads to the activation of Ras/MAPK and PI3-kinase downstream signaling,
    and the recruitment of p21 activated kinases 2 (PAK-2) via NCK, thus, inhibiting
    the pro-apoptotic protein Bcl-2-associated death (Bad).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATF6
  - JUN
  - AKT2
  - AKT3
  - AKT1
  - JUND
  - FOSL1
  - ARAF
  - RAF1
  - BRAF
  - BAD
  - BCL2
  - HSPA5
  - CDK4
  - CDK6
  - FOSB
  - FOSL2
  - JUNB
  - PKN2
  - PDIA5
  - HIF1A
  - ARNT
  - ERN1
  - MAPK8
  - MAPK9
  - MAPK10
  - MAPK14
  - FOS
  - MAPK13
  - MAPK12
  - MAPK3
  - MAPK1
  - MAP2K1
  - MAP2K2
  - MTOR
  - NCK1
  - PMAIP1
  - MAPK11
  - DLK1
  - AKR1C2
  - KRAS
  - NRAS
  - HRAS
  - Al
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: ATF6
  symbol: ATF6
  source: hgnc_symbol
  hgnc_symbol: ATF6
  entrez: '22926'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: BiP
  symbol: BiP
  source: hgnc_alias_symbol
  hgnc_symbol: HSPA5
  entrez: '3309'
- word: CDK4/
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: PAK-2
  symbol: Pak-2
  source: hgnc_alias_symbol
  hgnc_symbol: PKN2
  entrez: '5586'
- word: PDIA5
  symbol: PDIA5
  source: hgnc_symbol
  hgnc_symbol: PDIA5
  entrez: '10954'
- word: GRP78
  symbol: GRP78
  source: hgnc_prev_symbol
  hgnc_symbol: HSPA5
  entrez: '3309'
- word: HIF1.
  symbol: HIF1
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF1.
  symbol: HIF1
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: IRE1
  symbol: IRE1
  source: hgnc_alias_symbol
  hgnc_symbol: ERN1
  entrez: '2081'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NCK
  symbol: NCK
  source: hgnc_prev_symbol
  hgnc_symbol: NCK1
  entrez: '4690'
- word: NOXA
  symbol: NOXA
  source: hgnc_alias_symbol
  hgnc_symbol: PMAIP1
  entrez: '5366'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: D1,D2
  symbol: Delta1
  source: hgnc_alias_symbol
  hgnc_symbol: DLK1
  entrez: '8788'
- word: D1,D2
  symbol: DD2
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1C2
  entrez: '1646'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals:
- word: Al
  source: MESH
  identifier: D000535
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6468910__F4
redirect_from: /figures/PMC6468910__F4
figtype: Figure
---
